louisiana glp-1 lawsuit Risks of Ozempic, other drugs are at center of sweeping that kicked off in Philadelphia Louisiana is one of top

Early reports suggested a possible increase in thyroid tumors

Eli Lilly stock rallies as the firms oral weight-loss pill, Foundayo, secures FDA approval

Recently, a new class of drugs, based on GLP-1, are revolutionizing medicine and the treatment of patients with diabetes, obesity, and other disorders associated with obesity.

Designed for adults this formula is an ideal choice for those seeking targeted gut-centric wellness

CB0313.1 improved diabetic markers (fasting glucose, glucose tolerance, insulin tolerance, GLP-1 and insulin secretion), and decreased blood lipids and inflammatory tone

Note the launch of LillyDirect as an example of a branded, regulated pharmaceutical company going direct-to-consumer (DTC) beyond advertising to provide a service platform focused on obesity and weight management